Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton rats

Vaccine-enhanced disease has been a major obstacle in developing a safe vaccine against respiratory syncytial virus (RSV). This study demonstrates the immunogenicity, efficacy, and safety of virus-like particle (VLP) vaccines containing RSV F (F VLP), G (G VLP), or F and G proteins (FG VLP) in cotto...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Hum Vaccin Immunother
Asıl Yazarlar: Hwang, Hye Suk, Kim, Ki-Hye, Lee, Youri, Lee, Young-Tae, Ko, Eun-Ju, Park, SooJin, Lee, Jong Seok, Lee, Byung-cheol, Kwon, Young-Man, Moore, Martin L., Kang, Sang-Moo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2017
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5443399/
https://ncbi.nlm.nih.gov/pubmed/28129031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1272743
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller